Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …

Background The introduction of rituximab (R) to conventional CHOP chemotherapy for newly
diagnosed diffuse large B-cell lymphoma (DLBCL) led to an unequivocal improvement in …

Purpose: Hans and coworkers previously developed an immunohistochemical algorithm
with∼ 80% concordance with the gene expression profiling (GEP) classification of diffuse …

Most primary central nervous system lymphomas (PCNSLs) in immunocompetent patients
are diffuse large B-cell lymphomas (DLBCLs), characterized by poor prognosis, compared …

Purpose To study the main clinicobiologic features, response, and outcome of patients with
diffuse large B-cell lymphoma (DLBCL) according to the primary site, lymph node, or …

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's
lymphoma. Although it represents a curable disease, less than half of the patients are cured …

Diffuse large B-cell lymphoma (DLBCL) has been shown to be comprised of at least two
prognostic entities, depending on its resemblance to normal germinal center or activated B …

Purpose The heterogeneity of diffuse large B-cell lymphoma (DLBCL) has prompted the
search for new markers that can accurately separate prognostic risk groups. We previously …

We introduce a graph-theoretic approach to extract clusters and hierarchies in complex data-
sets in an unsupervised and deterministic manner, without the use of any prior information …

Purpose Outcome of diffuse large B-cell lymphoma (DLBCL) with a germinal center B-cell
(GCB) expression profile is superior to that of non-GCB DLBCL. This conclusion is mainly …